Raymond James Initiates Coverage On Regeneron Pharmaceuticals with Market Perform Rating

Raymond James analyst Dane Leone initiates coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) with a Market Perform rating.

Benzinga · 12/24/2019 11:16

Raymond James analyst Dane Leone initiates coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) with a Market Perform rating.